These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 35460073)

  • 1. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.
    Liao W; Du J; Wang Z; Feng Q; Liao M; Liu H; Yuan K; Zeng Y
    Int J Cancer; 2022 Aug; 151(3):337-347. PubMed ID: 35460073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role and mechanisms of noncoding RNAs in the regulation of metabolic reprogramming in bladder cancer (Review).
    Zhang B; Yang L; He Y; Han D; Qi P; Shang P
    Int J Mol Med; 2023 Sep; 52(3):. PubMed ID: 37477143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ncRNA-mediated fatty acid metabolism reprogramming in HCC.
    Xu K; Xia P; Chen X; Ma W; Yuan Y
    Trends Endocrinol Metab; 2023 May; 34(5):278-291. PubMed ID: 36890041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research progress of long-chain non-coding RNA in lipid metabolism reprogramming in primary hepatocellular carcinoma].
    Yu Z; Chen DM; Huang JL
    Zhonghua Gan Zang Bing Za Zhi; 2024 Feb; 32(2):180-185. PubMed ID: 38514271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-coding RNA mediated regulation of PI3K/Akt pathway in hepatocellular carcinoma: Therapeutic perspectives.
    Hussain MS; Moglad E; Afzal M; Gupta G; Hassan Almalki W; Kazmi I; Alzarea SI; Kukreti N; Gupta S; Kumar D; Chellappan DK; Singh SK; Dua K
    Pathol Res Pract; 2024 Jun; 258():155303. PubMed ID: 38728793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.
    Wong CM; Tsang FH; Ng IO
    Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):137-151. PubMed ID: 29317776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNAs in hepatocellular carcinoma metastasis: Remarkable indicators and potential oncogenic mechanism.
    Qiu W; Zhang S; Yu W; Liu J; Wu H
    Comput Biol Med; 2024 Sep; 180():108867. PubMed ID: 39089114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming.
    Chen M; Zhang C; Liu W; Du X; Liu X; Xing B
    Mol Ther; 2022 Jun; 30(6):2354-2369. PubMed ID: 35192933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging roles of non-coding RNAs in the metabolic reprogramming of tumor-associated macrophages.
    Li J; Lu Z; Zhang Y; Xia L; Su Z
    Immunol Lett; 2021 Apr; 232():27-34. PubMed ID: 33577913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress in the metabolic reprogramming of hepatocellular carcinoma (Review).
    Gao W; Wang J; Xu Y; Yu H; Yi S; Bai C; Cong Q; Zhu Y
    Mol Med Rep; 2024 Jul; 30(1):. PubMed ID: 38818815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoding hepatocarcinogenesis from a noncoding RNAs perspective.
    El-Aziz MKA; Dawoud A; Kiriacos CJ; Fahmy SA; Hamdy NM; Youness RA
    J Cell Physiol; 2023 Sep; 238(9):1982-2009. PubMed ID: 37450612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging roles and potential clinical applications of noncoding RNAs in hepatocellular carcinoma.
    Cao P; Jin Q; Feng L; Li H; Qin G; Zhou G
    Semin Cancer Biol; 2021 Oct; 75():136-152. PubMed ID: 32931952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects.
    Shang RZ; Qu SB; Wang DS
    World J Gastroenterol; 2016 Dec; 22(45):9933-9943. PubMed ID: 28018100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of noncoding RNAs in metabolic reprogramming of cancer cells.
    Safi A; Saberiyan M; Sanaei MJ; Adelian S; Davarani Asl F; Zeinaly M; Shamsi M; Ahmadi R
    Cell Mol Biol Lett; 2023 May; 28(1):37. PubMed ID: 37161350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things.
    Fang Y; Zhang X; Huang H; Zeng Z
    J Transl Med; 2023 Jun; 21(1):369. PubMed ID: 37286982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long noncoding RNA
    Ren Y; Shang J; Li J; Liu W; Zhang Z; Yuan J; Yang M
    J Biol Chem; 2017 Oct; 292(43):17939-17949. PubMed ID: 28887306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC.
    Rusu I; Pirlog R; Chiroi P; Nutu A; Puia VR; Fetti AC; Rusu DR; Berindan-Neagoe I; Al Hajjar N
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulating ferroptosis by non-coding RNAs in hepatocellular carcinoma.
    Sun L; Cao H; Wang Y; Wang H
    Biol Direct; 2024 Sep; 19(1):80. PubMed ID: 39267124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional long non-coding RNAs in hepatocellular carcinoma.
    Xie C; Li SY; Fang JH; Zhu Y; Yang JE
    Cancer Lett; 2021 Mar; 500():281-291. PubMed ID: 33129957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.